Perbedaan Organon Pharma Indonesia Tbk. dan Sekar Bumi Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sekar Bumi Tbk. diperdagangkan di Rp535 (kapitalisasi pasar 934,26 M, volume 24 jam 176,4 rb). Perbedaan utamanya: Sekar Bumi Tbk. jauh lebih besar — sekitar 8,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SKBM | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 934,26 M |
Volume | — | 176,4 rb |
Lot | — | 1,76 rb |
Perputaran | — | 93,56 jt |
Harga Rata-rata | — | 530,4 |
Nilai Transaksi | — | 93,56 jt |
Harga Ekuilibrium Indikatif | — | 535 |
Volume Ekuilibrium Indikatif | — | 22 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Sekar Bumi Tbk. ("hereinafter called the Company") was established within the framework of the Domestic Capital Investment Law No.6 year 1968, juncto No.12 year 1970 based on the notarial deed No. 42 dated April 12, 1973 of Djoko Supadmo, SH, notary in Surabaya. PT Sekar Bumi Tbk is an Indonesia-based manufacturing company. It operates plants to process maritime, farming and animal husbandry products. The Company has seven subsidiaries, which are engaged in the production of frozen food, cashew nut oil and animal feed. Headquartered in Surabaya, Indonesia, the Company also operates production facilities in Sidoarjo and Denpasar, as well as fish ponds in Bone and Mare in Sulawesi island.
Selengkapnya di halaman SKBM →